Previous Page  29 / 30 Next Page
Information
Show Menu
Previous Page 29 / 30 Next Page
Page Background

allied

academies

Journal of Physical Therapy and Sports Medicine

Volume 1, Issue 1

Euro Physiotherapy 2017

Notes:

Page 58

December 07-08, 2017 Rome, Italy

4

th

Euro-Global Physiotherapy Congress 2017

Autologous bone marrow-derived cell

therapy combined with physical therapy

induces functional improvement in chronic

spinal cord injury patients

Wael Abo El-kheir

1

, Hala Gabr

2

, Mohamed Reda Awad

3

, Osama

Ghannam

4

, Yousef Barakat

4

, Haithem A M A Farghali

5

, Zeinab M El

Maadawi

6

, Ibrahim Ewes

4

and

Hatem E Sabaawy

7

1

Military Medical Academy, Egypt

2

Cairo University, Cairo, Egypt

3

Al-Azhar University, Cairo, Egypt

4

Al-Azhar University, Cairo, Egypt

5

Cairo University, Cairo, Egypt

6

Department of Histology, Egypt

7

Rutgers–Cancer Institute of New Jersey, USA

S

pinal cord injuries (SCI) cause sensory loss and

motor paralysis and are treated with physical therapy,

but most patients fail to recover due to limited neural

regeneration. Here we describe a strategy in which

treatment with autologous adherent bone marrow cells

is combined with physical therapy to improve motor and

sensory functions in early-stage chronic SCI patients. In a

phase I/II controlled single-blind clinical trial (clinicaltrials.

gov identifier: NCT00816803), 70 chronic cervical and

thoracic SCI patients with injury durations of at least 6

months were treated with either intrathecal injection(s)

of autologous adherent bone marrow cells combined

with physical therapy, or with physical therapy alone.

Patients were evaluated with clinical examinations,

electrophysiological somatosensory evoked potential, MRI

imaging, and functional independence measurements.

Chronic cervical and thoracic SCI patients treated with

autologous adherent bone marrow cells combined with

physical therapy showed functional improvements over

patients in the control group treated with physical therapy

alone, and therewere no cell therapy-related side

effects.At

18 months posttreatment, 23 of the 50 cell therapy-treated

cases (46 percent) showed sustained improvement using

the American Spinal Injury Association (ASIA) Impairment

Scale (AIS). Compared to those patients with cervical

injuries, a higher rate of functional improvement was

achieved in thoracic SCI patients with shorter durations of

injury and smaller cord lesions. Therefore, when combined

with physical therapy, autologous adherent bone marrow

cell therapy appears to be a safe and promising therapy

for patients with chronic spinal cord injuries. Randomized

controlled multicenter trials are warranted.

Biography

Wael Abo El-Kheir is currently works as Professor of immunology &

Microbiology in military medical academy and he is the member of

the national committee for stem cells Egyptian ministry of health and also

honor as secretary of the Egyptian society of stem cells.

dr.wael2008@yahoo.com

Wael Abo El-kheir et al., J Phys Ther Sports Med 2017